Gardea-Gutiérrez Denisse, Román-Aguirre Manuel, Oseguera-Guerra Berenice E, Loera-Valencia Raúl, Montes-Fonseca Silvia L
Tecnologico de Monterrey, School of Engineering and Sciences, Chihuahua, Chih, Mexico.
Centro de Investigación en Materiales Avanzados CIMAV, Chihuahua, Chih, Mexico.
J Liposome Res. 2025 Jun 27:1-9. doi: 10.1080/08982104.2025.2521067.
The design of vehicles for transdermal gene delivery is at the forefront of molecular medicine, facilitating targeted therapies. Reports suggest that flexible liposomes can be a good alternative for transdermal delivery, and asymmetric liposomes may enhance gene delivery efficiency. This study aims to create flexible asymmetric-type liposomes with high encapsulation of DNA and high deformability rates. The synthesis of asymmetric liposomes was standardized using the inverse emulsion method, with lipids DOTMA (1,2-di-O-octadecenyl-3-trimethylammonium propane) and DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) as the inner layer, DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine) lipid as the outer layer, cholesterol as a stabilizing component, and Span 80 and ethanol as components that promote flexibility. The pIRES2-EGFP plasmid was used as the encapsulated genetic material. Asymmetric liposomes were characterized using transmission electron microscopy (TEM), encapsulation efficiency percentage (%EE), and the deformability index determined by the extrusion method. Results indicate that the asymmetric liposomes possess a well-defined bilayer, with bilayer deformability varying depending on the components used; for instance, liposomes containing flexible components exhibit a more deformable bilayer than those made solely of lipids. The average size of the liposomes was below 200 nm, and the %EE ranged from 75% to 90%. The liposomes containing Span 80 surfactant exhibited the highest flexibility index. This technique successfully produced asymmetric liposomes with appropriate encapsulation of the DNA plasmid without degradation during the process. Future studies are expected to evaluate the cytotoxicity, transfection, and skin permeation.
用于经皮基因递送的载体设计处于分子医学的前沿,有助于实现靶向治疗。报告表明,柔性脂质体可能是经皮递送的良好替代品,而不对称脂质体可能会提高基因递送效率。本研究旨在制备具有高DNA包封率和高变形率的柔性不对称型脂质体。采用反相乳液法对不对称脂质体的合成进行了标准化,以内层脂质DOTMA(1,2 - 二油酰基 - 3 - 三甲基铵丙烷)和DOPE(1,2 - 二油酰基 - sn - 甘油 - 3 - 磷酸乙醇胺)、外层脂质DSPC(1,2 - 二硬脂酰基 - sn - 甘油 - 3 - 磷酸胆碱)、胆固醇作为稳定成分以及Span 80和乙醇作为促进柔性的成分。使用pIRES2 - EGFP质粒作为包封的遗传物质。通过透射电子显微镜(TEM)、包封效率百分比(%EE)以及通过挤压法测定的变形性指数对不对称脂质体进行表征。结果表明,不对称脂质体具有明确的双层结构,双层的变形性因所用成分而异;例如,含有柔性成分的脂质体比仅由脂质制成的脂质体表现出更易变形的双层结构。脂质体的平均尺寸低于200 nm,%EE范围为75%至90%。含有Span 80表面活性剂的脂质体表现出最高的柔性指数。该技术成功制备了对DNA质粒具有适当包封且在过程中无降解的不对称脂质体。未来的研究有望评估其细胞毒性、转染和皮肤渗透性。